X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (23) 23
female (17) 17
oncology (17) 17
middle aged (16) 16
aged (13) 13
adult (11) 11
breast cancer (10) 10
antineoplastic combined chemotherapy protocols - therapeutic use (8) 8
breast neoplasms - mortality (8) 8
breast neoplasms - pathology (7) 7
follow-up studies (7) 7
survival rate (7) 7
breast neoplasms - drug therapy (6) 6
breast neoplasms - therapy (6) 6
cancer (6) 6
chemotherapy, adjuvant (6) 6
prognosis (6) 6
disease-free survival (5) 5
male (5) 5
therapy (5) 5
aged, 80 and over (4) 4
chemotherapy (4) 4
cyclophosphamide (4) 4
drug therapy (4) 4
immunohistochemistry (4) 4
lymphatic metastasis (4) 4
medicine & public health (4) 4
medicine, general & internal (4) 4
medroxyprogesterone acetate (4) 4
tamoxifen (4) 4
women (4) 4
5-fluorouracil caf (3) 3
adenosine triphosphate - therapeutic use (3) 3
antineoplastic agents, hormonal - therapeutic use (3) 3
care and treatment (3) 3
cyclophosphamide - administration & dosage (3) 3
diagnosis (3) 3
doxorubicin (3) 3
health aspects (3) 3
index medicus (3) 3
infusions, intravenous (3) 3
mortality (3) 3
prognostic factor (3) 3
quality of life (3) 3
randomized controlled trials as topic (3) 3
tamoxifen - therapeutic use (3) 3
treatment outcome (3) 3
adenosine triphosphate - administration & dosage (2) 2
age factors (2) 2
antineoplastic combined chemotherapy protocols - adverse effects (2) 2
bleomycin - administration & dosage (2) 2
bone marrow transplantation (2) 2
breast neoplasms - genetics (2) 2
breast neoplasms - metabolism (2) 2
breast neoplasms - radiotherapy (2) 2
breast neoplasms - surgery (2) 2
cancer and oncology (2) 2
cancer och onkologi (2) 2
cancer patients (2) 2
cause of death (2) 2
cell lung-cancer (2) 2
cisplatin - administration & dosage (2) 2
clinical medicine (2) 2
clinical trials (2) 2
combined modality therapy (2) 2
cyclophosphamide - therapeutic use (2) 2
disease (2) 2
doxorubicin - administration & dosage (2) 2
evaluation (2) 2
expression (2) 2
fatigue - etiology (2) 2
fatigue - prevention & control (2) 2
fluorouracil (2) 2
fluorouracil - administration & dosage (2) 2
klinisk medicin (2) 2
medical and health sciences (2) 2
medicin och hälsovetenskap (2) 2
medroxyprogesterone acetate - administration & dosage (2) 2
methotrexate (2) 2
neoplasm metastasis (2) 2
neoplasm recurrence, local - epidemiology (2) 2
neoplasm recurrence, local - prevention & control (2) 2
netherlands (2) 2
paclitaxel (2) 2
palliative care - methods (2) 2
patient outcomes (2) 2
pharmacology & pharmacy (2) 2
ploidies (2) 2
premenopausal women (2) 2
proportional hazards models (2) 2
prospective studies (2) 2
randomized clinical-trial (2) 2
receptors, estrogen - metabolism (2) 2
recurrence (2) 2
relapse (2) 2
research (2) 2
risk factors (2) 2
side effects (2) 2
skin and connective tissue diseases (2) 2
study protocol (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Lancet (British edition), ISSN 0140-6736, 2011, Volume 378, Issue 9793, pp. 771 - 784
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/1999, Volume 17, Issue 5, pp. 1413 - 1424
Purpose: This phase III study compared docetaxel with mitomycin plus vinblastine (MV) in patients with metastatic breast cancer (MBC) progressing despite... 
THERAPY | ONCOLOGY | DISEASE | PHASE-II | QLQ-C30 | 3-HOUR INFUSION | PACLITAXEL
Journal Article
by Abe, O and Abe, R and Enomoto, K and Kikuchi, K and Koyama, H and Masuda, H and Nomura, Y and Sakai, K and Sugimachi, K and Tominaga, T and Uchino, J and Yoshida, M and Haybittle, J.L and Davies, C and Harvey, V.J and Holdaway, T.M and Kay, R.G and Mason, B.H and Forbes, J.F and Wilcken, N and Gnant, M and Jakesz, R and Ploner, M and Yosef, H.M.A and Focan, C and Lobelle, J.P and Peek, U and Oates, G.D and Powell, J and Durand, M and Mauriac, L and Di Leo, A and Dolci, S and Piccart, M.J and Masood, M.B and Parker, D and Price, J.J and Hupperets, P.S.G.J and Jackson, S and Ragaz, J and Berry, D and Broadwater, G and Cirrincione, C and Muss, H and Norton, L and Weiss, R.B and Abu-Zahra, H.T and Portnoj, S.M and Baum, M and Cuzick, J and Houghton, J and Riley, D and Mansel, R.E and Gordon, N.H and Davis, H.L and Beatrice, A and Mihura, J and Naja, A and Lehingue, Y and Romestaing, P and Dubois, J.B and Delozier, T and Mace Lesec'h, J and Rambert, P and Petruzelka, L and Pribylova, O and Owen, J.R and Harbeck, N and Jänicke, F and Meisner, C and Meier, P and Howell, A and Ribeiro, G.C and Swindell, R and Burrett, J and Clarke, M and Collins, R and Darby, S and Davies, C and Elphinstone, P and Evans, V and Godwin, J and Gray, R and Harwood, C and Hicks, C and Jackson, D and James, S and MacKinnon, E and McGale, P and McHugh, T and Mead, G and Morris, P and Oulds, J and Peto, R and Taylor, C and Wang, Y and Albano, J and De Oliveira, C.F and Gervásio, H and Gordilho, J and ... and unav and Early Breast Cancer Trialists' Collaborative Group (EBCTCG) and Oxford CTSU and EBCTC and Early Breast Cancer Trialists Collaborative Group (EBCTCG)
The Lancet (British edition), ISSN 0140-6736, 2005, Volume 366, Issue 9503, pp. 2087 - 2106
Journal Article
Journal of the National Cancer Institute. Monographs, ISSN 1745-6614, 2010, Volume 2010, Issue 41, pp. 162 - 177
Journal Article
The Lancet, ISSN 0140-6736, 2005, Volume 365, Issue 9472, pp. 1687 - 1717
Journal Article
Journal Article